Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04533464 · ClinicalTrials.gov registry record · Phase 2
MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
A Phase 2 study of Trauma and Adult Stem Cells, sponsored by Healios K.K..
- Recruiting
- Registry status
- Phase 2
- Development phase
- 156
- Enrollment target
- 1
- Study location
NCT04533464 is a Phase 2 study of Trauma and Adult Stem Cells that is actively recruiting participants, run by Healios K.K.. The registered enrollment target is 156 participants, below the 305-participant average among 56 other Trauma trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04533464, a Phase 2 study of Trauma and Adult Stem Cells, is actively recruiting participants, sponsored by Healios K.K..
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 156 participants
- Enrollment target
- 1
- Study location
Study Summary
Single center, prospective, randomized, double-blind, pragmatic Phase 2 clinical study in severely injured trauma patients within hours of hospitalization who have survived initial resuscitation.
Conditions Studied
Interventions
- BIOLOGICAL Placebo
- BIOLOGICAL MultiStem
Study Locations (1)
Texas
- Healios Investigational Site - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2020-11-09 |
| Est. Completion | 2025-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04533464
The ClinicalTrials.gov registry entry for NCT04533464 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 305-participant average among 56 other Trauma trials with a reported enrollment target (49% lower). The listed sponsor is Healios K.K., which has 6 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Trauma appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04533464 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04533464 about?
NCT04533464 is a clinical study titled "MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome". Single center, prospective, randomized, double-blind, pragmatic Phase 2 clinical study in severely injured trauma patients within hours of hospitalization who have survived initial resuscitation.
What is the current status of trial NCT04533464?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 156 participants. The study started on 2020-11-09. Estimated completion is 2025-12.
What conditions does trial NCT04533464 study?
This clinical trial studies the following conditions: Trauma, Adult Stem Cells.
What interventions are being tested in trial NCT04533464?
The interventions under investigation include: Placebo (BIOLOGICAL), MultiStem (BIOLOGICAL).
Who is sponsoring clinical trial NCT04533464?
This trial is sponsored by Healios K.K., which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04533464 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trauma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
RECRUITING · Phase 2
-
A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients
RECRUITING · Phase 2
-
Humacyte Human Acellular Vessel (HAV) in Patients With Vascular Trauma
ACTIVE NOT RECRUITING · Phase 2
-
Testing FIRST in Youth Outpatient Psychotherapy
RECRUITING · NA
-
PRESERVE & CONNECT: Impact Study of the BPC
RECRUITING · NA
-
Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.